Tag Archives: Lung

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell… Read More »

Johnson & Johnson snares FDA nod for first exon 20-targeted drug in EGFR lung cancer

Just a few short months after Johnson & Johnson’s Janssen unit sent its targeted non-small cell lung cancer drug amivantamab to the FDA, the regulator has come back with a green light—a very specific one. Now christened Rybrevant, the drug is the first-ever treatment for non-small cell lung cancer with a group of epidermal growth factor receptor (EGFR) mutations found in… Read More »

Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What about the Opdivo combo?

Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent from rival Bristol Myers Squibb would offer additional benefit. Turns out, doing that adds more harm and no good. Merck decided to stop adding Bristol Myers’ CTLA-4 inhibitor Yervoy to Keytruda in… Read More »

Do Lung Cancer Guidelines Undercount Black Americans?

Despite findings that Black Americans are more likely to die of lung cancer than white Americans, current screening guidelines fail to properly count this population, according to new findings published in the International Association for the Study of Lung Cancer’s Journal of Thoracic Oncology. Black people have different patterns of smoking and lung cancer. They… Read More »